Vimarsana
Biggest News Aggregation in the World

Page 8 - Spin Out News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spin Out. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spin Out Today - Breaking & Trending Today

'Vegan spider silk' provides sustainable alternative to single-use plastics - Vimarsana News

'Vegan spider silk' provides sustainable alternative to single-use plastics

Researchers have created a plant-based, sustainable, scalable material that could replace single-use plastics in many consumer products. It was a surprise to find our research could also address a big problem in sustainability: that of plastic pollution Tuomas Knowles The researchers, from the University of Cambridge, created a polymer film by mimicking the properties of spider silk, one of the strongest materials in nature. The new material is as strong as many common plastics in use today and could replace plastic in many common household products. The material was created using a new appro...

Source: cam.ac.uk
Codebase Ventures Inc.: Codebase Receives Positive Technical Study Results for HCQ Transdermal Patch Technology - Vimarsana News

Codebase Ventures Inc.: Codebase Receives Positive Technical Study Results for HCQ Transdermal Patch Technology

Codebase Ventures Inc.: Codebase Receives Positive Technical Study Results for HCQ Transdermal Patch Technology Viability to Address Underserved Lupus, Rheumatoid Arthritis and Malaria market, forecast to be worth $6 Billion USD by 2027*, Company to investigate Spin Out of Asset VANCOUVER, BC / ACCESSWIRE / April 1, 2021 / Codebase Ventures Inc. ("Codebase" or the "Company") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on the continued development of the Company's proposed transdermal delivery technology for hydroxychloroquine (HCQ), as first announced in April 2020. The C...

Marvel Discovery Corp. Announces Extraordinary General Meeting to Approve Spinout Transaction - Vimarsana News

Marvel Discovery Corp. Announces Extraordinary General Meeting to Approve Spinout Transaction

Marvel Discovery Corp. Announces Extraordinary General Meeting to Approve Spinout Transaction Marvel Discovery Corp. (TSXV:MARV)(Frankfurt:O4T1)(OTC PINK:IMTFF); (" Marvel" or the Company") announces that an extraordinary general meeting of the shareholders of the Company has been scheduled for April 23, 2021 at 10:00 a.m. Pacific Time (the " EGM"). The purpose of the EGM is to, among other things, consider and, if thought fit, approve a special resolution with respect to a plan of arrangement (the " Spin-Out") pursuant to which the Company will spin out its Serpent River/Pecors and Wicheeda ...

Opto Diode Introduces Two-Stage Cooled Mid-Infrared Detector - Vimarsana News

Opto Diode Introduces Two-Stage Cooled Mid-Infrared Detector

Camarillo, Calif. – Opto Diode Corporation, an ITW company, introduces a high-performance, two-stage, cooled, lead selenide (PbSe) detector that operates in the mid-infrared (IR) spectral region with peak sensitivity between 4.3 and 4.5µm. The cooler on the BXT2S-28T allows the detector element to operate as low as -45 °C to maximize detectivity (D*). The device also features excellent responsivity of 7.5 x 104 V/W (typical). The exceptionally reliable detector provides the highest sensitivity when monitoring small changes in gas mixtures. Real-time measurements are easily supported with...

Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19 - Vimarsana News

Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19

Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19 JERUSALEM, March 9, 2021 /PRNewswire/ -- Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus, responsible for the COVID-19 outbreak. The company, PeptiCov, will implement Pepticom's AI technology to design, discover and develop novel peptide molecules for effective treatment of the SARS-Cov-2 virus. The funding round was led by the Chartered Group. "Unfortunately, COVID-19 and the vari...